A5083951703- Antiplatelet Therapy and Cardiovascular Diseases
- Heparin-Induced Thrombocytopenia and Thrombosis
- Animal testing and alternatives
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Inflammatory mediators and NSAID effects
- Liver Disease Diagnosis and Treatment
- Adipose Tissue and Metabolism
- Dietary Effects on Health
- Diet and metabolism studies
- Infrared Thermography in Medicine
- Lipoproteins and Cardiovascular Health
The First Affiliated Hospital, Sun Yat-sen University
2024
Sun Yat-sen University
2024
Non-alcoholic fatty liver disease (NAFLD) has emerged as a global health concern, lacking specific therapeutic strategies. Time-restricted feeding (TRF) regimen demonstrated beneficial effects in NAFLD; however, the underlying mechanisms remain unclear. In this study, we established NAFLD mouse model through high-fat diet (HFD) and implemented 16:8 TRF for duration of 6 weeks. We that remarkably alleviated hepatic steatosis HFD mice. Of note, aldehyde oxidase 1 (AOX1), key enzyme...
Glycoursodeoxycholic acid (GUDCA) has been acknowledged for its ability to regulate lipid homeostasis and provide benefits various metabolic disorders. However, the impact of GUDCA on arterial thrombotic events remains unexplored. The objective this study is examine effects thrombogenesis elucidate underlying mechanisms.